They do, however, highlight an important role for increased oxidative stress defense as a potential therapeutic strategy for AMD, corroborating recent data obtained with the HTRA1/ARMS2‐iPSC model and exposure to nicotinamide 25. This evidence concerns the gene ARMS2 and age-related macular degeneration.